US2003069298A1PendingUtilityA1
Crystals including a malic acid salt of a 3-pyrrole substituted 2-indolinone, and compositions thereof
Est. expiryAug 15, 2021(expired)· nominal 20-yr term from priority
A61P 35/00A61P 3/10A61P 35/02A61P 43/00A61P 17/06C07D 403/06
43
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention provides crystals, and compositions thereof, wherein the crystals include a malic acid salt of N-[2-(diethylamino)ethyl]-5-[(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide. Methods of preparing such crystals are also disclosed.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . An anhydrous crystal comprisng a malic acid salt of a compound having the structure:
2 . The crystal of claim 1 , wherein the malic acid is L-malic acid.
3 . An anhydrous crystal comprising a malic acid salt of N-[2-(diethylamino)ethyl]-5-[(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide.
4 . A crystal comprising a malic acid salt of N-[2-(diethylamino)ethyl]-5-[(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide, wherein the crystal has characteristic diffraction peaks at about 13.2 and 24.2 degrees two-theta in a powder X-ray diffraction pattern.
5 . The crystal of claim 4 having characteristic diffraction peaks at about 13.2, 19.4, 24.2, and 25.5 degrees two-theta in a powder X-ray diffraction pattern.
6 . The crystal of claim 5 having characteristic diffraction peaks in a powder X-ray diffraction pattern as listed in Table 1 for Crystal Form I.
7 . The crystal of claim 4 further comprising at most about 2% by weight water.
8 . The crystal of claim 7 comprising at most about 0.5% by weight water.
9 . The crystal of claim 8 comprising at most about 0.2% by weight water.
10 . A crystal comprising a malic acid salt of N-[2-(diethylamino)ethyl]-5-[(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide, wherein the crystal has a melting point of at least about 190° C.
11 . The crystal of claim 10 having a melting point of at least about 195° C.
12 . The crystal of claim 10 further comprising at most about 2% by weight water.
13 . The crystal of claim 12 comprising at most about 0.5% by weight water.
14 . The crystal of claim 13 comprising at most about 0.2% by weight water.
15 . A crystal comprising a malic acid salt of N-[2-(diethylamino)ethyl]-5-[(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide, wherein the crystal has characteristic diffraction peaks at about 3.0 and 27.7 degrees two-theta in a powder X-ray diffraction pattern.
16 . The crystal of claim 15 having characteristic diffraction peaks at about 3.0, 12.1, 14.5, and 27.7 degrees two-theta in a powder X-ray diffraction pattern.
17 . The crystal of claim 16 having characteristic diffraction peaks in a powder X-ray diffraction pattern as listed in Table 1 for Crystal Form II.
18 . The crystal of claim 15 , wherein the crystal absorbs at least about 5% by weight water upon exposure to 80% relative humidity.
19 . A crystal comprising a malic acid salt of N-[2-(diethylamino)ethyl]-5-[(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide, wherein the crystal has a melting point of at most about 185° C.
20 . The crystal of claim 19 , wherein the crystal absorbs at least about 5% by weight water upon exposure to 80% relative humidity.
21 . A method of preparing an anhydrous crystal comprising a malic acid salt of N-[2-(diethylamino)ethyl]-5-[(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide, the method comprising:
combining malic acid; N-[2-(diethylamino)ethyl]-5-[(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide; and a solvent; and inducing the salt to crystallize under crystallization conditions comprising one or more factors comprising: a difference between the initial and final temperatures of the crystallization solution of at most about 100° C.; a rate of cooling of at most about 50° C. per hour; no seeding; a supersaturation ratio of at most about 10; no precipitant; and/or combinations thereof.
22 . The method of claim 21 , wherein the malic acid is L-malic acid.
23 . The method of claim 21 , wherein the one or more factors comprise: a difference between the initial and final temperatures of the crystallization solution of at most about 50° C.; a rate of cooling of at most about 20° C. per hour; a supersaturation ratio of at most about 5; and/or combinations thereof.
24 . The method of claim 23 , wherein the one or more factors comprise: a difference between the initial and final temperatures of the crystallization solution of at most about 25° C.; a rate of cooling of at most about 2° C. per hour; a supersaturation ratio of at most about 1.5; and/or combinations thereof.
25 . The method of claim 24 , wherein the initial and final temperatures of the crystallization solution are the same.
26 . The method of claim 21 , wherein the solvent is selected from the group consisting of acetonitrile, methanol, ethanol, isopropanol, toluene, n-butanol, tetrahydrofuran, N,N-dimethylformamide, acetone, water, and combinations thereof.
27 . The method of claim 21 , wherein the anhydrous crystal has characteristic diffraction peaks at about 13.2 and 24.2 degrees two-theta in a powder X-ray diffraction pattern.
28 . The crystal of claim 27 having characteristic diffraction peaks at about 13.2, 19.4, 24.2, and 25.5 degrees two-theta in a powder X-ray diffraction pattern.
29 . The crystal of claim 28 having characteristic diffraction peaks in a powder X-ray diffraction pattern as listed in Table 1 for Crystal Form I.
30 . A method of preparing an anhydrous crystal comprising a malic acid salt of N-[2-(diethylamino)ethyl]-5-[(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide, the method comprising contacting a crystal comprising a malic acid salt of N-[2-(diethylamino)ethyl]-5-[(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide with a solvent in which the contacting crystal has substantial solubility, wherein the contacting crystal has characteristic diffraction peaks at about 3.0 and 27.7 degrees two-theta in a powder X-ray diffraction pattern.
31 . The method of claim 30 , wherein the contacting crystal has characteristic diffraction peaks at about 3.0, 12.1, 14.5, and 27.7 degrees two-theta in a powder X-ray diffraction pattern.
32 . The method of claim 3 1 , wherein the contacting crystal has characteristic diffraction peaks in a powder X-ray diffraction pattern as listed in Table 1 for Crystal Form II.
33 . The method of claim 30 , wherein the solvent is selected from the group consisting of acetonitrile, ethanol, methanol, and combinations thereof.
34 . The method of claim 30 , wherein contacting the crystal with the solvent forms a slurry.
35 . The method of claim 34 further comprising stirring the slurry.
36 . The method of claim 34 further comprising heating the slurry.
37 . The method of claim 34 further comprising removing the anhydrous crystal from the slurry.
38 . The method of claim 30 , wherein the anhydrous crystal has characteristic diffraction peaks at about 13.2 and 24.2 degrees two-theta in a powder X-ray diffraction pattern.
39 . The method of claim 38 , wherein the anhydrous crystal has characteristic diffraction peaks at about 13.2, 19.4, 24.2, and 25.5 degrees two-theta in a powder X-ray diffraction pattern.
40 . The method of claim 39 , wherein the anhydrous crystal has characteristic diffraction peaks in a powder X-ray diffraction pattern as listed in Table 1 for Crystal Form I.
41 . A method of preparing a crystal comprising a malic acid salt of N-[2-(diethylamino)ethyl]-5-[(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide, the method comprising:
combining malic acid; N-[2-(diethylamino)ethyl]-5-[(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide; and a solvent; and inducing the salt to crystallize under crystallization conditions comprising one or more factors comprising: a difference between the initial and final temperatures of the crystallization solution of at least about 25° C.; a rate of cooling of at least about 25° C. per hour; seeding; a supersaturation ratio of at least about 2; presence of a precipitant; and/or combinations thereof.
42 . The method of claim 41 , wherein the malic acid is L-malic acid.
43 . The method of claim 41 , wherein the one or more factors comprise: a difference between the initial and final temperatures of the crystallization solution of at least about 50° C.; a rate of cooling of at least about 100° C. per hour; a supersaturation ratio of at least about 5; and/or combinations thereof.
44 . The method of claim 43 , wherein the one or more factors comprise: a difference between the initial and final temperatures of the crystallization solution of at least about 100° C.; a rate of cooling of at least about 300° C. per hour; a supersaturation ratio of at least about 10; and/or combinations thereof.
45 . The method of claim 41 , wherein the solvent is selected from the group consisting of methanol, water, tetrahydrofuran/water mixtures, and combinations thereof.
46 . The method of claim 41 , wherein the crystal has characteristic diffraction peaks at about 3.0 and 27.7 degrees two-theta in a powder X-ray diffraction pattern.
47 . The method of claim 46 , wherein the crystal has characteristic diffraction peaks at about 3.0, 12.1, 14.5, and 27.7 degrees two-theta in a powder X-ray diffraction pattern.
48 . The method of claim 47 , wherein the crystal has characteristic diffraction peaks in a powder X-ray diffraction pattern as listed in Table 1 for Crystal Form II.
49 . A composition comprising anhydrous crystals comprising a malic acid salt of N-[2-(diethylamino)ethyl]-5-[(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide.
50 . The composition of claim 49 further comprising an excipient.
51 . A composition comprising crystals comprising a malic acid salt of N-[2-(diethylamino)ethyl]-5-[(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide, wherein the crystals have characteristic diffraction peaks at about 13.2 and 24.2 degrees two-theta in a powder X-ray diffraction pattern.
52 . A composition comprising crystals comprising a malic acid salt of N-[2-(diethylamino)ethyl]-5-[(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide, wherein the crystals have a melting point of at least about 190° C.
53 . A composition comprising crystals comprising a malic acid salt of N-[2-(diethylamino)ethyl]-5-[(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide, wherein the crystals have characteristic diffraction peaks at about 3.0 and 27.7 degrees two-theta in a powder X-ray diffraction pattern.
54 . A composition comprising crystals comprising a malic acid salt of N-[2-(diethylamino)ethyl]-5-[(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide, wherein the crystals have a melting point of at most about 185° C.Join the waitlist — get patent alerts
Track US2003069298A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.